Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05022862 · ClinicalTrials.gov registry record · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
A NA study of Latent Tuberculosis, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 399
- Enrollment target
- 1
- Study location
NCT05022862 is a NA study of Latent Tuberculosis that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 399 participants, below the 1,126-participant average among 5 other Latent Tuberculosis trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05022862, a NA study of Latent Tuberculosis, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 399 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate a novel and scalable intervention that combines Video Directly Observed Therapy (vDOT) and financial incentives to promote completion of treatment for latent tuberculosis. Adult participants who are initiating treatment for latent tuberculosis will be recruited from the Baltimore City Health Department. The primary hypothesis is that the incentive intervention will increase the percentage of participants that complete the treatment for latent tuberculosis above the completion rates of participants receiving usual care.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Video Directly Observed Therapy alone
- BEHAVIORAL Video Directly Observed Therapy plus Financial Incentives
Study Locations (1)
Maryland
- Baltimore City Health Department, and Baltimore metropolitan area clinics and health departments - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2022-02-07 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05022862
The ClinicalTrials.gov registry entry for NCT05022862 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 399 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,126-participant average among 5 other Latent Tuberculosis trials with a reported enrollment target (65% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Latent Tuberculosis appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT05022862 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05022862 about?
NCT05022862 is a clinical study titled "Economic Incentives and vDOT for Latent Tuberculosis Infection". The purpose of this study is to evaluate a novel and scalable intervention that combines Video Directly Observed Therapy (vDOT) and financial incentives to promote completion of treatment for latent tuberculosis. Adult participants who are initiating treatment for latent tuberculosis will be recruit...
What is the current status of trial NCT05022862?
This trial is currently recruiting. It is a NA study. The enrollment target is 399 participants. The study started on 2022-02-07. Estimated completion is 2027-12-01.
What conditions does trial NCT05022862 study?
This clinical trial studies the following conditions: Latent Tuberculosis.
What interventions are being tested in trial NCT05022862?
The interventions under investigation include: Usual Care (BEHAVIORAL), Video Directly Observed Therapy alone (BEHAVIORAL), Video Directly Observed Therapy plus Financial Incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT05022862?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05022862 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Latent Tuberculosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brief Educational Video for Patients Prescribed LTBI Treatment
ACTIVE NOT RECRUITING · NA
-
Training Protocol on the Natural History of Tuberculosis
RECRUITING
-
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
RECRUITING · Phase 2
-
One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
ACTIVE NOT RECRUITING · Phase 4
-
Immune Response to Mycobacterium Tuberculosis Infection
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.